ISRCTN48534559进行中（未招募）未知
MAMMO-50: mammographic surveillance in breast cancer patients aged 50 years and over: a randomised controlled trial
niversity of Warwick (UK)0 个研究点目标入组 6,150 人开始时间: 2014年2月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 6,150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Female, age >= 50 at initial cancer diagnosis
- •2. Excised invasive breast cancer with local treatment completed
- •3. Three years post curative surgery date
- •4. Written informed consent for the study
排除标准
- •1. Breast cancer recurrence, new breast cancer primary or any new malignancies
- •2. Previous diagnosis of malignancy unless managed by surgical treatment only and disease free for 10 years or previous basal cell carcinoma of skin, cervical intraepithelial neoplasia or in situ ductal carcinoma of the breast treated with surgery only
研究者
相似试验
招募中
不适用
Observational study on breast cancer detection using autoantibodies against the antigen of cancer stem cellsBreast cancerJPRN-UMIN000045144Sapporo Medical University350
尚未招募
不适用
Tumorresponse monitoring in patients with breast cancer treated with primary systemic therapy: Towards predicting response in both the primary tumor and in axillary lymph nodescarcinoma10006291breast cancerNL-OMON31961Antoni van Leeuwenhoek Ziekenhuis300
尚未招募
不适用
Breast Cancer Screening : The prevalence of breast cancer in transgender people in Thailand.Transgender peopleBreast cancerTransgender menTransgender womenBreast cancer screeningawarenessprevalenceTCTR20200817005Center of Excellence in Transgender Health, CETH2,610
招募中
不适用
Blood test for screening of breast cancer using novel screening device, Pandora CDx MammoAlertTMCTRI/2017/05/008716POC Medical Systems Inc2,400
已完成
不适用
on-invasive monitoring of breast cancer therapy using circulating tumor DNA from peripheral bloodMetastatic breast cancerNL-OMON43952Erasmus MC, Universitair Medisch Centrum Rotterdam90